RxDoctor Payments Data

Abby Stroeh, DO

Family Medicine · Des Moines, IANPI 1255823951

Payments from drug & device makers

$470in general payments, 2019–2025

Across 29 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$171
  • Pfizer$86
  • Amgen$56
  • Lilly USA, LLC$44
  • Astellas Pharma US Inc$29
  • Novo Nordisk$28
  • plus $55 from 3 others

What the payments were for

  • Food & beverage$470100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$470 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$15,776
Medicare patients
56
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban149$71,669
Invega SustennaPaliperidone Palmitate12$22,092
JanuviaSitagliptin Phosphate32$20,203
OzempicSemaglutide19$17,865
JardianceEmpagliflozin31$17,824
MyrbetriqMirabegron26$12,424
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$11,004
MounjaroTirzepatide12$10,029
XareltoRivaroxaban12$7,503
Bevespi AerosphereGlycopyrrolate/Formoterol Fum12$5,345
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$3,081
Quinidine Gluconate13$2,769
Gabapentin119$1,728
Potassium Chloride53$1,462
Baclofen52$1,307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$86$71,669149 claims
Novo NordiskOzempic$28$17,86519 claims
Astellas Pharma US IncMyrbetriq$29$12,42426 claims
Lilly USA, LLCMounjaro$44$10,02912 claims
AbbVieSynthroid$171$53312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →